Feedback / Questions
obexelimab (ZB012) - Zenas BioPharma
https://www.globenewswire.com/news-release/2026/02/09/3234414/0/en/zenas-biopharma-announces-late-breaking-platform-presentation-of-results-from-phase-2-moonstone-trial-of-obexelimab-in-relapsing-multiple-sclerosis-at-actrims-forum-2026.html
Feb 11, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next